Emily A Hu1, Elizabeth Selvin1, Morgan E Grams2, Lyn M Steffen3, Josef Coresh1, Casey M Rebholz4. 1. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. 2. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD; Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD. 3. Division of Epidemiology and Community Health, University of Minnesota School of Public Health, Minneapolis, MN. 4. Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, MD; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Electronic address: crebhol1@jhu.edu.
Abstract
BACKGROUND: Moderate coffee consumption has been suggested to be associated with lower risk for chronic conditions such as diabetes, a major precursor to chronic kidney disease (CKD). However, the association between coffee and CKD has not been fully established. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 14,209 participants aged 45 to 64 years from the Atherosclerosis Risk in Communities (ARIC) Study. PREDICTORS: Coffee consumption (cups per day) was assessed at visits 1 (1987-1989) and 3 (1993-1995) using food frequency questionnaires. OUTCOMES: Incident CKD defined as estimated glomerular filtration rate < 60mL/min/1.73m2 accompanied by ≥25% estimated glomerular filtration rate decline, CKD-related hospitalization or death, or end-stage renal disease. RESULTS: There were 3,845 cases of incident CKD over a median of 24 years of follow-up. Men, whites, current smokers, and participants without comorbid conditions were more likely to consume higher amounts of coffee per day. After adjustment for demographic, clinical, and dietary factors, higher categories of coffee consumption were associated with lower risk for incident CKD compared with those who never consumed coffee (HR for <1 cup per day, 0.90 [95% CI, 0.82-0.99]; 1-<2 cups per day, 0.90 [95% CI, 0.82-0.99]; 2-<3 cups per day, 0.87 [95% CI, 0.77-0.97]; and ≥3 cups per day, 0.84 [95% CI, 0.75-0.94]). In continuous analysis, for each additional cup of coffee consumed per day, risk for incident CKD was lower by 3% (HR, 0.97; 95% CI, 0.95-0.99; P<0.001). LIMITATIONS: Self-reported coffee consumption and observational design. CONCLUSIONS: Participants who drank higher amounts of coffee had lower risk for incident CKD after adjusting for covariates. Coffee consumers may not be at adverse risk for kidney disease.
BACKGROUND: Moderate coffee consumption has been suggested to be associated with lower risk for chronic conditions such as diabetes, a major precursor to chronic kidney disease (CKD). However, the association between coffee and CKD has not been fully established. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 14,209 participants aged 45 to 64 years from the Atherosclerosis Risk in Communities (ARIC) Study. PREDICTORS: Coffee consumption (cups per day) was assessed at visits 1 (1987-1989) and 3 (1993-1995) using food frequency questionnaires. OUTCOMES: Incident CKD defined as estimated glomerular filtration rate < 60mL/min/1.73m2 accompanied by ≥25% estimated glomerular filtration rate decline, CKD-related hospitalization or death, or end-stage renal disease. RESULTS: There were 3,845 cases of incident CKD over a median of 24 years of follow-up. Men, whites, current smokers, and participants without comorbid conditions were more likely to consume higher amounts of coffee per day. After adjustment for demographic, clinical, and dietary factors, higher categories of coffee consumption were associated with lower risk for incident CKD compared with those who never consumed coffee (HR for <1 cup per day, 0.90 [95% CI, 0.82-0.99]; 1-<2 cups per day, 0.90 [95% CI, 0.82-0.99]; 2-<3 cups per day, 0.87 [95% CI, 0.77-0.97]; and ≥3 cups per day, 0.84 [95% CI, 0.75-0.94]). In continuous analysis, for each additional cup of coffee consumed per day, risk for incident CKD was lower by 3% (HR, 0.97; 95% CI, 0.95-0.99; P<0.001). LIMITATIONS: Self-reported coffee consumption and observational design. CONCLUSIONS:Participants who drank higher amounts of coffee had lower risk for incident CKD after adjusting for covariates. Coffee consumers may not be at adverse risk for kidney disease.
Authors: Erikka Loftfield; Neal D Freedman; Barry I Graubard; Kristin A Guertin; Amanda Black; Wen-Yi Huang; Fatma M Shebl; Susan T Mayne; Rashmi Sinha Journal: Am J Epidemiol Date: 2015-11-27 Impact factor: 4.897
Authors: W J Arion; W K Canfield; F C Ramos; P W Schindler; H J Burger; H Hemmerle; G Schubert; P Below; A W Herling Journal: Arch Biochem Biophys Date: 1997-03-15 Impact factor: 4.013
Authors: Anna Floegel; Tobias Pischon; Manuela M Bergmann; Birgit Teucher; Rudolf Kaaks; Heiner Boeing Journal: Am J Clin Nutr Date: 2012-02-15 Impact factor: 7.045
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Marc J Gunter; Neil Murphy; Amanda J Cross; Laure Dossus; Laureen Dartois; Guy Fagherazzi; Rudolf Kaaks; Tilman Kühn; Heiner Boeing; Krasimira Aleksandrova; Anne Tjønneland; Anja Olsen; Kim Overvad; Sofus Christian Larsen; Maria Luisa Redondo Cornejo; Antonio Agudo; María José Sánchez Pérez; Jone M Altzibar; Carmen Navarro; Eva Ardanaz; Kay-Tee Khaw; Adam Butterworth; Kathryn E Bradbury; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Domenico Palli; Sara Grioni; Paolo Vineis; Salvatore Panico; Rosario Tumino; Bas Bueno-de-Mesquita; Peter Siersema; Max Leenders; Joline W J Beulens; Cuno U Uiterwaal; Peter Wallström; Lena Maria Nilsson; Rikard Landberg; Elisabete Weiderpass; Guri Skeie; Tonje Braaten; Paul Brennan; Idlir Licaj; David C Muller; Rashmi Sinha; Nick Wareham; Elio Riboli Journal: Ann Intern Med Date: 2017-07-11 Impact factor: 25.391
Authors: Nirmala Bhoo-Pathy; Petra H M Peeters; Cuno S P M Uiterwaal; H Bas Bueno-de-Mesquita; Awang M Bulgiba; Bodil Hammer Bech; Kim Overvad; Anne Tjønneland; Anja Olsen; Françoise Clavel-Chapelon; Guy Fagherazzi; Florence Perquier; Birgit Teucher; Rudolf Kaaks; Madlen Schütze; Heiner Boeing; Pagona Lagiou; Philippos Orfanos; Antonia Trichopoulou; Claudia Agnoli; Amalia Mattiello; Domenico Palli; Rosario Tumino; Carlotta Sacerdote; Franzel J B van Duijnhoven; Tonje Braaten; Eiliv Lund; Guri Skeie; María-Luisa Redondo; Genevieve Buckland; Maria José Sánchez Pérez; Maria-Dolores Chirlaque; Eva Ardanaz; Pilar Amiano; Elisabet Wirfält; Peter Wallström; Ingegerd Johansson; Lena Maria Nilsson; Kay-Tee Khaw; Nick Wareham; Naomi E Allen; Timothy J Key; Sabina Rinaldi; Isabelle Romieu; Valentina Gallo; Elio Riboli; Carla H van Gils Journal: Breast Cancer Res Date: 2015-01-31 Impact factor: 6.466
Authors: Andrés Díaz-López; Indira Paz-Graniel; Verónica Ruiz; Estefanía Toledo; Nerea Becerra-Tomás; Dolores Corella; Olga Castañer; J Alfredo Martínez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramon Estruch; Francisco J Tinahones; José Lapetra; Luís Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Lidia Daimiel; Tania Fernandez Villa; Emilio Ros; Sonia Eguaras; Nancy Babio; Jose V Sorlí; Albert Goday; Itziar Abete; Lucas Tojal Sierra; Francisco Javier Barón-López; Laura Torres-Collado; Marga Morey; Antonio Garcia-Rios; Rosa Casas; María Rosa Bernal-López; José Manuel Santos-Lozano; Adela Navarro; Jose I Gonzalez; María Dolores Zomeño; Maria Angeles Zulet; Jessica Vaquero Luna; Raul Ramallal; Montse Fitó; Jordi Salas-Salvadó Journal: Sci Rep Date: 2021-04-22 Impact factor: 4.379
Authors: William J He; Jingsha Chen; Alexander C Razavi; Emily A Hu; Morgan E Grams; Bing Yu; Chirag R Parikh; Eric Boerwinkle; Lydia Bazzano; Lu Qi; Tanika N Kelly; Josef Coresh; Casey M Rebholz Journal: Clin J Am Soc Nephrol Date: 2021-11-04 Impact factor: 8.237
Authors: Kalie L Tommerdahl; Carissa Vinovskis; Lu-Ping Li; Casey M Rebholz; Cameron Severn; Emily A Hu; Elizabeth Selvin; Josef Coresh; Morgan E Grams; Pottumarthi Prasad; Chirag R Parikh; Petter Bjornstad Journal: Kidney Int Rep Date: 2022-05-04
Authors: Jongeun Rhee; Erikka Loftfield; Neal D Freedman; Linda M Liao; Rashmi Sinha; Mark P Purdue Journal: Int J Epidemiol Date: 2021-11-10 Impact factor: 7.196
Authors: Anam Tariq; Jingsha Chen; Bing Yu; Eric Boerwinkle; Josef Coresh; Morgan E Grams; Casey M Rebholz Journal: J Ren Nutr Date: 2021-07-20 Impact factor: 4.354